Cleared Traditional

K143159 - Cannulated PediGuard Needle#1, Cannulated PediGuard Needle#2, Cannulated PediGuard Needle 120mm, Cannulated PediGuard Handle

Also marketed or referenced as:
PediGuard Tri Tip Ø4.0mm, PediGuard Tri Tip Ø3.2mm, PediGuard Tri Tip Ø2.5mm, PediGuard Ø2.5mm XS, PediGuard Curv, PediGuard Curv XS

K143159 is an FDA 510(k) clearance for Cannulated PediGuard Needle#1, manufactured by Spineguard S.A.. The device is a Class 2 Neurology device with product code PDQ cleared through the Traditional 510(k) pathway after a 81-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2015
Decision
81d
Days
Class 2
Risk

K143159 is an FDA 510(k) clearance for the Cannulated PediGuard Needle#1, Cannulated PediGuard Needle#2, Cannulated Pedi.... Classified as Neurosurgical Nerve Locator (product code PDQ), Class II - Special Controls.

Submitted by Spineguard S.A. (Saint Mande, FR). The FDA issued a Cleared decision on January 23, 2015 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 874.1820 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Spineguard S.A. devices

FDA 510(k) Submission Details - K143159

510(k) Number K143159 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 2014
Decision Date January 23, 2015
Days to Decision 81 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 149d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PDQ Device Classification - Class 2, Special Controls

Product Code PDQ Neurosurgical Nerve Locator
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 874.1820
Definition To Locate Or Monitor Function Of Spinal Nerve Roots Or Peripheral Nerves During Neurosurgery.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Orgenix, LLC
Donald W. Guthner

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PDQ Neurosurgical Nerve Locator

All 35
Devices cleared under the same product code (PDQ) and FDA review panel - the closest regulatory comparables to K143159.
NuVasiveNVM5 System
K152942 · Nu Vasive, Incorporated · Jan 2016
NuVasive NVM5 System
K143641 · Nu Vasive, Incorporated · Mar 2015
Nerve Monitoring Cable System
K142438 · Pioneer Surgical Technology, Inc. (Rti Surgical, Inc.) · Mar 2015
NUVASIVE NVM5 SYSTEM
K141968 · Nuvasive, Inc. · Nov 2014
PHANTOM XL INSULATED DILATORS
K140088 · Tedan Surgical Innovations, LLC · Sep 2014
SENTIO MMG
K131304 · Innovative Surgical Solutions, LLC ("Iss") · May 2014